Company on track for first subject treated in pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) in the first quarter of 2025 Trial designed for possible accelerated approval of Annamycin ...

DSMB recommends continuing Phase 3 DRAGON trial for Tinlarebant in Stargardt disease without modifications; completion expected Q4 2025. Tinlarebant has received Fast ...

BERWYN, Pa.--(BUSINESS WIRE)--Annovis Bio, Inc. (NYSE: ANVS), announces the positive safety review by the Data and Safety Monitoring Board (DSMB) for its phase 2/3 trial of buntanetap, a drug ...

PHILADELPHIA and VANCOUVER, British Columbia, June 24, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage ...

PEPPER PIKE, Ohio -- The Orange Board of Education has approved a guaranteed maximum price of just over $3 million for Phase 2 of the high school refresh project. The estimate, approved 3-0 by the ...

STATELINE, Nev. – The Tahoe Regional Planning Agency (TRPA) governing board met to recognize Laurie Hockenberry’s service and to conduct a workshop on Phase 3 of Cultivating Community, Conserving the ...